While the pharmaceutical industry has made billions of dollars from treating erectile dysfunction, penis enlargement remains a niche industry, dominated by the devices marketed by a single urologist. Writing for the New Yorker and ProPublica, Ava Kofman explores the poorly regulated world of penile implants and the devastating harm to patients whose experience with them has gone horribly wrong. |